Psychedelic substances could help with depression: old drugs as remedy for PTSD
Cairns Post, January 2, 2021
A Therapeutic Goods Administration decision on psychedelic drugs in the New Year could offer hope to Far Northern sufferers of PTSD and depression.
MDMA and magic mushrooms to be used to treat Australians with mental health issues
Daily Telegraph, December 18, 2020
Exclusive: In the first course of its kind in the southern hemisphere, 100 Australian doctors, psychiatrists, psychologists, mental health care nurses, social workers and occupational therapists will be trained and ready to treat patients with party drugs such as MDMA and magic mushrooms.
Million Ideas Episode 1 – Treating mental illness with psilocybin and MDMA
Million Ideas, December 7, 2020
This first episode is an interview with Tania De Jong of Mind Medicine Australia a charity helping advance the use of psilocybin and MDMA to treat mental illness.
3 Part Series – National Regulator takes on United Nation’s convention. How psychedelic medicine is becoming a reality in Australia
Cannabis Law Report, December 1, 2020
This is Part 1 of a 3 part series we will be publishing over the next few weeks about Australia’s place in the ever-quickening world of regulated psilocybin and MDMA penned by Mind Medicine Australia (MMA)
Podcast with Kyle Buller and Joe Moore (USA) from Psychedelics Today and Tania de Jong AM
Psychedelics Today, November 24, 2020
In this episode, Kyle Buller and Joe Moore (USA) interview singer, speaker, social entrepreneur, and founder of numerous charities and organizations, Tania de Jong AM.
Mind Medicine Australia pushes forward with new partner
Byron Echo, November 23, 2020
As Mind Medicine Australia awaits the results of a rescheduling application before the Therapeutic Goods Administration to allow psychedelic medications to be used more widely in clinical therapy, the charity organisation has announced a new partnership with the company Emyria.
Unstress Podcast with Tania de Jong AM and Dr Ron Ehrlich
Unstress Podcast, October 21, 2020
Mind Medicine Australia’s Executive Director and Co-Founder, Tania de Jong AM explains why she established Mind Medicine Australia and how it aims to help alleviate the suffering caused by mental illness in Australia through expanding the treatment options available to medical practitioners and their patients.
Podcast with Ari Delashmutt and Tania De Jong AM
Ari Delashmut, Ari in the Air Podcast, September 26, 2020
In this wide-ranging podcast, Tania de Jong AM speaks to podcast host Ari Delashmutt about the work that Mind Medicine Australia is doing to allow psychedelic treatments for clinical use in Australia.
Psychedelics as medicine?
Byron Healing, September 9, 2020
NSW Greens MP Cate Faehrmann recently hosted an online webinar with Tania de Jong AM and Peter Hunt AM from Mind Medicine Australia, looking at the emerging role of psychedelics in mental health treatment.
MDMA and psilocybin considered in Australia for psychotherapy use
Newcastle Herald, September 4, 2020
A psychiatrist has called for people suffering from treatment-resistant post-traumatic stress disorder [PTSD] to be allowed access to MDMA-assisted psychotherapy. Dr Stuart Saker, whose practice is based in Toronto near Newcastle, NSW, said many of his patients were military veterans and emergency service workers.
Is Psychedelics The Answer to Our Mental Health Crisis?
Mamamia, The Quicky Podcast, September 4, 2020
In this wide-ranging podcast, Tania de Jong AM relates that studies are being done with psychedelic drugs in various ways hoping that they might be a silver bullet for the treatment of mental illness. Since the widespread use of them in the 1960s and their links to the counterculture of the time, the drugs haven’t been taken seriously – until now.
Mind Medicine Australia Submits Australian-First Application for the Rescheduling of Psilocybin and MDMA
Mind Medicine Australia, September 1, 2020
Mind Medicine Australia has submitted Australia’s first applications to the Therapeutic Goods Administration (TGA) to reschedule Psilocybin and MDMAso that they can be more easily used as part of clinical therapies for the treatment of major classes of mental illness.
Treating mental illness with mushies and MDMA: The regulator wants to know what you think
ABC, September 1, 2020
Mind Medicine Australia, a not-for-profit that wants psychiatrists to be able to use these drugs in therapy sessions, has applied to the national health regulator to enable mental health professionals to more easily access these medicines.
We’re experiencing a growing mental health crisis. We need more innovative solutions
Pro Bono Australia, August 24, 2020
Tania de Jong AM, co-founder of charity Mind Medicine Australia, says current treatment options are unable to adequately address the “mental health tsunami” being created by the COVID crisis.
Healing the Planet’s Suffering with Plant Medicines
The Third Wave Podcast, August 4, 2020
In this wide-ranging podcast, Tania de Jong and Paul F. Austin talk about mental health, surviving trauma, the mind-altering power of music, catapulting into the cosmos with psychedelics, kangaroos, and folding umbrellas.
The Psychedelic Renaissance
Australasian Science, July 1, 2020
Recent studies are finding that psychedelic medicines are effective treatments for mental health disorders such as depression, anxiety, post-traumatic stress disorder and addiction.
Mind Revealing Medicines
The Project, Channel 10, July 1, 2020
Calls to Beyond Blue have increased by 60% during the COVID-19 crisis. Mind Medicine Australia’s Tania de Jong AM and Dr Prash Puspanathan are interviewed by The Project on the radical need for innovation in mental health treatments now. Joel Harrop, ex-ADF veteran also shares his story and credits these medicines for saving his life.
Peter Hunt AM, Founder, Mind Medicine Australia presents at the ShareCafe Psychedelic Stocks Webinar
Sharecafe 25, June 25, 2020
Peter Hunt, Founder, Mind Medicine Australia presents at the ShareCafe Psychedelic Stocks Webinar on June 19, 2020. Mind Medicine Australia is a charity that enables the development of regulatory-approved and research-backed psychedelic-assisted psychotherapy for the treatment of mental ill-health in Australia.